Is Atorvastatin Associated with New Onset Diabetes or Deterioration of Glycemic Control? Systematic Review Using Data from 1.9 Million Patients.
Angeliki M AngelidiEmelina StambolliuKonstantina I AdamopoulouAntonis A KousoulisPublished in: International journal of endocrinology (2018)
This systematic review suggests that there is an association between atorvastatin treatment and NOD. Moreover, it showed that atorvastatin in high dose causes worsening of the glycemic control in patients with DM.
Keyphrases
- glycemic control
- systematic review
- type diabetes
- blood glucose
- high dose
- meta analyses
- weight loss
- end stage renal disease
- insulin resistance
- newly diagnosed
- ejection fraction
- peritoneal dialysis
- randomized controlled trial
- machine learning
- stem cell transplantation
- adipose tissue
- big data
- skeletal muscle
- replacement therapy
- smoking cessation